Pharmafile Logo
Pharmafocus logo
Advanced Search

Chong Kun Dang Pharm Licenses Synaffix ADC Technology, Adds Novel ADC Candidate to Oncology Pipeline

February 6, 2023
Business Services

THE NETHERLANDS and SOUTH KOREA, 6 February 2023 — Synaffix B.V., a biotechnology company focused on commercializing its clinical-stage platform …

News
Press release

Oxford University scientists’ AI diagnostic test accurately identifies known respiratory viruses in minutes

February 6, 2023
Business Services

February 6th, 2023 – Oxford, United Kingdom – Nicolas Shiaelis and 

News
Press release

Patients with hidradenitis suppurativa experienced sustained efficacy and symptom improvement at one year when treated with Novartis Cosentyx®

February 6, 2023
Business Services

Basel, February 4, 2023 – Novartis announced today that The Lancet has published long-term data from the pivotal SUNSHINE and …

News
Press release

SPR Therapeutics gains FDA extended approval for pain management system

February 6, 2023
Research and Development

Pain management medical device company SPR Therapeutics has obtained expanded approval from the FDA for its SPRINT Peripheral Nerve System …

News

Australia’s TGA approves psychedelics to treat mental health conditions

February 6, 2023
Research and Development

Australia’s Therapeutic Goods Administration (TGA) has announced its approval of the use of psychedelics to treat certain mental health conditions. …

News

Daiichi Sankyo to build Japan’s first factory for mRNA COVID-19 vaccines

February 6, 2023
Manufacturing and Production

Daiichi Sankyo have announced its plans to build Japan’s first factory for mRNA COVID-19 vaccines. The new facility is expected …

News

Boston Scientific fined $42m over patent infringement

February 6, 2023
Medical Communications

A five-year legal battle between Boston Scientific and TissueGen has culminated in a $42m fine, which Boston Scientific must pay …

News

Businesses from the UK are in the top four foreign investors in Flanders in 2022

February 3, 2023
Business Services

Investment figures released this week by Flanders Investment & Trade show that UK businesses are continuing to make significant investments …

News
Press release

IMFINZI (DURVALUMAB) IN COMBINATION WITH GEMCITABINE AND CISPLATIN APPROVED IN GREAT BRITAIN AS A FIRST-LINE TREATMENT FOR ADULT PATIENTS WITH LOCALLY ADVANCED, UNRESECTABLE OR METASTATIC BILIARY TRACT CANCER

February 3, 2023
Business Services

London, UK, Thursday 2 February 2023 – AstraZeneca today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has …

News
Press release

MHRA Approves RINVOQ®▼ (upadacitinib) as First Oral Advanced Therapy to Treat Adults with Moderately to Severely Active Crohn’s Disease

February 3, 2023
Business Services

MAIDENHEAD, UK, 01 February 2023 – AbbVie (NYSE: ABBV) today announced that the UK Medicines and Healthcare products Regulatory Agency …

News
Press release

Phlo raises £10m to spearhead digital transformation in pharmacy sector

February 3, 2023
Business Services

[Glasgow, Scotland]  Phlo, UK digital pharmacy leaders, have closed a £10m Series A round led by family office Thairm Bio.   …

News
Press release

Drug-resistant bacteria found in eye drops has infected 55 people in 12 states

February 3, 2023
Medical Communications

A strongly drug-resistant bacteria has been found in multiple brands of artificial tears eyedrops; the most commonly reported was EzriCare …

News

DrugBAN AI expected to reduce costs and speed up drug discovery

February 3, 2023
Medical Communications

In a collaboration between Sheffield University and pharma giant, AstraZeneca, a new AI has been developed which could help deliver …

News

Genoscience Pharma received Orphan Drug Designation for hepatocellular carcinoma drug

February 3, 2023
Medical Communications

French clinical-stage biotech company Genoscience has received FDA Orphan Drug Designation (ODD) for its lead candidate ezurpimtrostat. OOD qualifies the …

News

Insilico Medicine opens new R&D facility in Abu Dhabi

February 3, 2023
Research and Development

Hong Kong-based healthtech company Insilico Medicine recently opened its eighth global laboratory in Abu Dhabi.   Utilising Abu Dhabi’s Masdar …

News

Novartis announces cut to multiple drug research programmes in 2022 full-year report

February 2, 2023
Business Services

Novartis, a Swiss pharmaceutical company, has announced in its 2022 full-year report that it is cutting several of their programmes, …

News
shaking-hands-gb7ac17374_1920

Sherlock Biosciences acquires Sense Biodetection to advance CRISPR-based diagnostics

February 2, 2023
Business Services

US-based biotech company Sherlock Biosciences has acquired UK-based developer of rapid molecular diagnostics Sense Biodetection.   The acquisition will integrate …

News

Tadashi Maruno

February 2, 2023
Sales and Marketing

  Hamamatsu Photonics Announces Mr. Tadashi Maruno as Representative Director and PresidentHamamatsu Photonics, a leading provider of cutting-edge photonics technology, …

Appointment
illumina_joydeep_goswami

Joydeep Goswami

February 2, 2023
Sales and Marketing

Illumina Appoints Joydeep Goswami Chief Financial Officer

Appointment

PureTech to Present at the SVB Securities Global Biopharma Conference

February 1, 2023
Business Services

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company dedicated to changing the treatment …

News
Press release
The Gateway to Local Adoption Series

Latest content

Five Facts about spinal muscular atrophy

January 28, 2026

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026

Everdrone appoints David Borkmann as Senior Medical Advisor

January 28, 2026

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026